QA: PUMA Biotechnology INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001401667_2013_PUMA_Biotechnology_INC.pdf

Logs

Graph

Absolute values for 0001401667, PUMA Biotechnology INC

  xvar xval
0 AssetsCurrent 148,972,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,479,000
3 remainder_Assets 1,248,000
4 LiabilitiesCurrent 21,701,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,089,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,814,000
9 ResearchAndDevelopmentExpense 49,636,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 98,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 151,699,000
1 Liabilities 22,790,000
2 Expenses 74,450,000
3 Revenues 0
4 StockholdersEquity 128,909,000
5 NetIncome -74,352,000
6 ComprehensiveNetIncome -74,352,000
7 BaseVar 124,518,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.37
9 EconomicCapitalRatio 3.27

Edgar->Model Mapping

Feature Distribution

Change over Time